Textron Aviation today announced the delivery of the 100th Beechcraft King Air 360 turboprop to the Comprehensive Blood and Cancer Center (CBCC), a long-time Textron Aviation customer. This delivery further solidifies Beechcraft King Air's place as the most popular family of turboprop business aircraft in the world.
The CBCC is a pioneer in global cancer care, including cutting-edge clinical trials that have led to new drug developments in cancer treatment. Working for decades with the UCLA TRIO Network, the CBCC has provided patients with access to new clinical trials. Many of these clinical trials have changed the way cancer therapy is delivered today. The CBCC CRO (Clinical Research Organization) also offers patients access to clinical trials around the world.
Nearly 7.800 Beechcraft King Air turboprops have been delivered to customers worldwide since 1964, making it the world's best-selling business turboprop family. The worldwide fleet has sured 62 million flight hours in its 59 years, serving roles in all branches of the U.S. military and flying commercial and special mission roles around the world.
Read also
- Textron Aviation presents the new Citation CJ3 Gen2
- GOL is returning another Boeing 737-800
- Helisul invests in a more comfortable and modern Operational Control Center
Street: Textron Aviation
